In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report), with a ...
In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), ...
Securities adjusted its outlook on Albemarle Corporation (NYSE:ALB), a leading producer of lithium, by reducing its price target from $105.00 to $90.00, while keeping a Neutral rating on the stock.
The Japan Fair Trade Commission on April 13 rebuked Mizuho Securities Co. for setting initial public offering (IPO) prices of newly listed stocks too low, which could lead to violating the Anti ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...
The S&P 500 notched another record. The Dow and Nasdaq were also higher Wednesday after the stock market reacted to minutes from the Federal Reserve's January meeting.
Midstream company Energy Transfer plans to use the proceeds from its $3 billion offering of senior notes to refinance ...
Diversified Energy Company PLC (LSE: DEC; NYSE: DEC) (“Diversified” or the "Company"), an independent energy company focused on natural gas and liquids production, transportation, marketing and well ...